Short Interest in FT Vest U.S. Equity Deep Buffer ETF – October (BATS:DOCT) Rises By 855.5%

FT Vest U.S. Equity Deep Buffer ETF – October (BATS:DOCT) was the target of a significant increase in short interest in the month of July. As of July 31st, there was short interest totaling 18,402 shares, an increase of 855.5% from the July 15th total of 1,926 shares. Based on an average trading volume of 7,799 shares, the days-to-cover ratio is currently 2.4 days. Approximately 0.2% of the company’s shares are short sold.

Institutional Inflows and Outflows

A hedge fund recently raised its position in FT Vest U.S. Equity Deep Buffer ETF – October stock. Winnow Wealth LLC raised its holdings in FT Vest U.S. Equity Deep Buffer ETF – October (BATS:DOCT) by 4,725.7% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 121,993 shares of the company’s stock after acquiring an additional 119,465 shares during the quarter. FT Vest U.S. Equity Deep Buffer ETF – October makes up 4.1% of Winnow Wealth LLC’s holdings, making the stock its 5th largest holding. Winnow Wealth LLC owned about 1.48% of FT Vest U.S. Equity Deep Buffer ETF – October worth $5,490,000 as of its most recent SEC filing.

FT Vest U.S. Equity Deep Buffer ETF – October Price Performance

Shares of FT Vest U.S. Equity Deep Buffer ETF – October stock traded up $0.08 during trading on Thursday, hitting $47.61. The stock had a trading volume of 253 shares, compared to its average volume of 11,639. The firm’s fifty day simple moving average is $46.76 and its 200-day simple moving average is $45.51. The stock has a market cap of $391.83 million, a PE ratio of 24.90 and a beta of 0.37. FT Vest U.S. Equity Deep Buffer ETF – October has a 12 month low of $41.80 and a 12 month high of $48.42.

About FT Vest U.S. Equity Deep Buffer ETF – October

The FT Cboe Vest U.S. Equity Deep Buffer ETF – October (DOCT) is an exchange-traded fund that mostly invests in large cap equity. The fund aims for specific buffered losses and capped gains on the SPY over a specific holdings period. The actively-managed fund holds options and collateral. DOCT was launched on Oct 16, 2020 and is managed by First Trust.